| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.781 | 0.004 | 0.819 | Vasodilator, peripheral | 0.806 0.004 DBMET00984 0.819 0.004 DBMET00985 0.693 0.007 DBMET00986 | DBMET00985 | |
| 0.776 | 0.003 | 0.776 | Diuretic | 0.727 0.004 DBMET00984 0.753 0.003 DBMET00985 0.506 0.007 DBMET00986 | ||
| 0.596 | 0.013 | 0.677 | Spasmolytic | 0.677 0.007 DBMET00984 0.436 0.033 DBMET00985 0.245 0.093 DBMET00986 | DBMET00984 | |
| 0.572 | 0.002 | 0.664 | Angiotensin-converting enzyme inhibitor | 0.339 0.003 DBMET00984 0.664 0.002 DBMET00985 0.365 0.003 DBMET00986 | DBMET00985 | |
| 0.578 | 0.019 | 0.768 | Immunostimulant | 0.768 0.005 DBMET00984 0.567 0.021 DBMET00985 0.586 0.018 DBMET00986 | DBMET00984 | |
| 0.545 | 0.009 | 0.599 | Vasodilator | 0.599 0.006 DBMET00984 0.536 0.009 DBMET00985 0.45 0.016 DBMET00986 | DBMET00984 | |
| 0.539 | 0.008 | 0.562 | Psychostimulant | 0.46 0.015 DBMET00984 0.562 0.007 DBMET00985 0.254 0.057 DBMET00986 | DBMET00985 | |
| 0.497 | 0.016 | 0.612 | Vasodilator, coronary | 0.612 0.007 DBMET00984 0.408 0.033 DBMET00985 0.248 0.137 DBMET00986 | DBMET00984 | |
| 0.489 | 0.025 | 0.586 | Immunomodulator | 0.586 0.013 DBMET00984 0.536 0.018 DBMET00985 0.565 0.015 DBMET00986 | DBMET00984 | |
| 0.43 | 0.042 | 0.739 | Antithrombotic | 0.739 0.006 DBMET00984 0.4 0.049 DBMET00985 0.279 0.104 DBMET00986 | DBMET00984 | |
| 0.413 | 0.027 | 0.413 | Cardiotonic | 0.263 0.074 DBMET00984 0.403 0.028 DBMET00985 0.21 0.11 DBMET00986 | ||
| 0.447 | 0.068 | 0.699 | Cyclophilin D inhibitor | 0.699 0.014 DBMET00984 0.487 0.054 DBMET00985 0.607 0.026 DBMET00986 | DBMET00984 | |
| 0.387 | 0.021 | 0.479 | Interleukin agonist | 0.479 0.01 DBMET00984 0.428 0.015 DBMET00985 0.237 0.088 DBMET00986 | DBMET00984 | |
| 0.373 | 0.014 | 0.431 | Thrombolytic | 0.406 0.011 DBMET00984 0.431 0.009 DBMET00985 0.348 0.017 DBMET00986 | DBMET00985 | |
| 0.388 | 0.031 | 0.472 | Interleukin 2 agonist | 0.472 0.012 DBMET00984 0.456 0.014 DBMET00985 0.398 0.028 DBMET00986 | DBMET00984 | |
| 0.374 | 0.033 | 0.433 | Platelet antagonist | 0.433 0.022 DBMET00984 0.417 0.024 DBMET00985 0.268 0.065 DBMET00986 | DBMET00984 | |
| 0.356 | 0.031 | 0.683 | Angiogenesis stimulant | 0.683 0.005 DBMET00984 0.383 0.025 DBMET00985 0.36 0.03 DBMET00986 | DBMET00984 | |
| 0.362 | 0.054 | 0.362 | 5 Hydroxytryptamine release stimulant | 0.312 0.066 DBMET00984 0.243 0.093 DBMET00985 | ||
| 0.324 | 0.024 | 0.374 | Anticoagulant | 0.37 0.019 DBMET00984 0.374 0.019 DBMET00985 0.234 0.042 DBMET00986 | DBMET00985 | |
| 0.333 | 0.042 | 0.535 | Hypoglycemic | 0.535 0.013 DBMET00984 0.3 0.053 DBMET00985 0.389 0.029 DBMET00986 | DBMET00984 | |
| 0.378 | 0.087 | 0.4 | Histamine release inhibitor | 0.4 0.076 DBMET00984 0.266 0.144 DBMET00985 0.255 0.151 DBMET00986 | DBMET00984 | |
| 0.311 | 0.026 | 0.354 | Gastrin inhibitor | 0.212 0.13 DBMET00984 0.354 0.01 DBMET00985 | DBMET00985 | |
| 0.285 | 0.003 | 0.285 | Leukocyte elastase inhibitor | 0.214 0.004 DBMET00985 | ||
| 0.284 | 0.009 | 0.414 | Neurotrophic factor | 0.266 0.01 DBMET00984 0.323 0.007 DBMET00985 0.414 0.005 DBMET00986 | DBMET00986 | |
| 0.327 | 0.075 | 0.548 | Cholesterol antagonist | 0.548 0.025 DBMET00984 0.25 0.125 DBMET00985 0.209 0.157 DBMET00986 | DBMET00984 | |
| 0.23 | 0.004 | 0.274 | Acetylcholine release stimulant | 0.274 0.004 DBMET00984 0.155 0.014 DBMET00985 | DBMET00984 | |
| 0.241 | 0.022 | 0.241 | Anesthetic local | 0.106 0.078 DBMET00985 | ||
| 0.34 | 0.124 | 0.34 | 5 Hydroxytryptamine release inhibitor | |||
| 0.318 | 0.104 | 0.463 | Immunosuppressant | 0.463 0.043 DBMET00984 0.318 0.104 DBMET00985 0.446 0.048 DBMET00986 | DBMET00984 | |
| 0.33 | 0.12 | 0.381 | Analgesic | 0.381 0.093 DBMET00985 | DBMET00985 | |
| 0.213 | 0.018 | 0.255 | Aminopeptidase B inhibitor | 0.255 0.012 DBMET00985 | DBMET00985 | |
| 0.174 | 0.003 | 0.184 | Prolyl endopeptidase inhibitor | 0.11 0.005 DBMET00984 0.184 0.003 DBMET00985 0.065 0.02 DBMET00986 | DBMET00985 | |
| 0.256 | 0.091 | 0.261 | Insulysin inhibitor | 0.261 0.087 DBMET00985 | DBMET00985 | |
| 0.191 | 0.027 | 0.281 | Cell adhesion inhibitor | 0.266 0.013 DBMET00984 0.244 0.016 DBMET00985 0.281 0.011 DBMET00986 | DBMET00986 | |
| 0.198 | 0.04 | 0.198 | Thiol protease inhibitor | 0.176 0.051 DBMET00985 | ||
| 0.194 | 0.038 | 0.229 | Neurotensin receptor agonist | 0.229 0.025 DBMET00985 | DBMET00985 | |
| 0.161 | 0.018 | 0.21 | Folate antagonist | 0.125 0.035 DBMET00984 0.21 0.009 DBMET00985 0.11 0.049 DBMET00986 | DBMET00985 | |
| 0.246 | 0.13 | 0.597 | Transcription factor NF kappa B inhibitor | 0.597 0.031 DBMET00984 0.21 0.159 DBMET00985 0.285 0.103 DBMET00986 | DBMET00984 | |
| 0.12 | 0.006 | 0.183 | Dipeptidyl peptidase inhibitor | 0.183 0.004 DBMET00985 | DBMET00985 | |
| 0.214 | 0.102 | 0.357 | DNA synthesis inhibitor | 0.357 0.029 DBMET00984 0.226 0.088 DBMET00985 0.332 0.034 DBMET00986 | DBMET00984 | |
| 0.134 | 0.025 | 0.143 | Interleukin 1 beta converting enzyme inhibitor | 0.143 0.02 DBMET00985 | DBMET00985 | |
| 0.243 | 0.136 | 0.304 | Sodium/bile acid cotransporter inhibitor | 0.304 0.076 DBMET00985 0.24 0.139 DBMET00986 | DBMET00985 | |
| 0.127 | 0.021 | 0.167 | Cell adhesion molecule inhibitor | 0.167 0.012 DBMET00984 0.166 0.013 DBMET00985 0.144 0.016 DBMET00986 | DBMET00984 | |
| 0.174 | 0.07 | 0.174 | Antipruritic | 0.173 0.071 DBMET00985 | ||
| 0.107 | 0.004 | 0.12 | Prolactin release inhibitor | 0.082 0.009 DBMET00984 0.12 0.003 DBMET00985 0.09 0.006 DBMET00986 | DBMET00985 | |
| 0.113 | 0.014 | 0.113 | Elastase 1 inhibitor | 0.095 0.023 DBMET00985 | ||
| 0.103 | 0.004 | 0.127 | HCV NS3/NS4A protease inhibitor | 0.069 0.015 DBMET00984 0.127 0.003 DBMET00985 0.072 0.014 DBMET00986 | DBMET00985 | |
| 0.146 | 0.049 | 0.146 | Proteasome inhibitor | 0.12 0.065 DBMET00985 | ||
| 0.169 | 0.074 | 0.255 | Growth hormone agonist | 0.255 0.042 DBMET00985 0.137 0.099 DBMET00986 | DBMET00985 | |
| 0.128 | 0.033 | 0.17 | Opioid antagonist | 0.092 0.054 DBMET00984 0.17 0.02 DBMET00985 0.086 0.062 DBMET00986 | DBMET00985 | |
| 0.118 | 0.023 | 0.157 | Hematopoietic | 0.157 0.014 DBMET00985 0.082 0.067 DBMET00986 | DBMET00985 | |
| 0.235 | 0.143 | 0.891 | Apoptosis antagonist | 0.421 0.033 DBMET00984 0.246 0.131 DBMET00985 0.891 0.003 DBMET00986 | DBMET00986 | |
| 0.175 | 0.084 | 0.175 | P-glycoprotein inhibitor | 0.163 0.098 DBMET00984 0.151 0.116 DBMET00985 | ||
| 0.215 | 0.124 | 0.324 | 5 Hydroxytryptamine uptake stimulant | 0.324 0.034 DBMET00985 | DBMET00985 | |
| 0.115 | 0.025 | 0.136 | Analgesic, opioid | 0.09 0.037 DBMET00984 0.136 0.018 DBMET00985 0.103 0.03 DBMET00986 | DBMET00985 | |
| 0.098 | 0.01 | 0.098 | Elastase inhibitor | 0.053 0.038 DBMET00984 0.097 0.011 DBMET00985 | ||
| 0.176 | 0.089 | 0.207 | Anesthetic general | 0.207 0.071 DBMET00984 | DBMET00984 | |
| 0.173 | 0.086 | 0.39 | Hepatoprotectant | 0.39 0.014 DBMET00984 0.162 0.097 DBMET00985 0.226 0.051 DBMET00986 | DBMET00984 | |
| 0.128 | 0.042 | 0.128 | Protease inhibitor | 0.107 0.059 DBMET00984 0.126 0.043 DBMET00985 | ||
| 0.138 | 0.056 | 0.199 | Cathepsin H inhibitor | 0.199 0.023 DBMET00985 | DBMET00985 | |
| 0.085 | 0.005 | 0.134 | Neutral endopeptidase inhibitor | 0.134 0.004 DBMET00985 0.038 0.01 DBMET00986 | DBMET00985 | |
| 0.083 | 0.007 | 0.137 | Dipeptidyl peptidase IV inhibitor | 0.137 0.004 DBMET00985 | DBMET00985 | |
| 0.1 | 0.025 | 0.108 | Thrombin inhibitor | 0.081 0.041 DBMET00984 0.108 0.022 DBMET00985 | DBMET00985 | |
| 0.102 | 0.031 | 0.14 | Opioid mu receptor antagonist | 0.071 0.046 DBMET00984 0.14 0.02 DBMET00985 | DBMET00985 | |
| 0.097 | 0.026 | 0.097 | Calcium channel L-type blocker | |||
| 0.075 | 0.004 | 0.155 | Angiotensin-converting enzyme 2 inhibitor | 0.017 0.012 DBMET00984 0.155 0.003 DBMET00985 0.022 0.007 DBMET00986 | DBMET00985 | |
| 0.173 | 0.103 | 0.177 | Insulin sensitizer | 0.177 0.098 DBMET00985 | DBMET00985 | |
| 0.149 | 0.08 | 0.186 | Interferon gamma antagonist | 0.186 0.047 DBMET00984 0.185 0.047 DBMET00985 0.17 0.057 DBMET00986 | DBMET00984 | |
| 0.09 | 0.033 | 0.14 | Opioid delta receptor antagonist | 0.14 0.022 DBMET00985 | DBMET00985 | |
| 0.154 | 0.097 | 0.186 | Phospholipase C inhibitor | 0.186 0.055 DBMET00985 | DBMET00985 | |
| 0.096 | 0.039 | 0.118 | Opioid kappa receptor antagonist | 0.118 0.024 DBMET00985 | DBMET00985 | |
| 0.078 | 0.026 | 0.09 | Glutamate (mGluR6) antagonist | 0.09 0.016 DBMET00985 | DBMET00985 | |
| 0.098 | 0.046 | 0.098 | Acetylcholine M3 receptor agonist | |||
| 0.056 | 0.006 | 0.076 | Glutamate (mGluR8) antagonist | 0.076 0.004 DBMET00985 0.041 0.016 DBMET00986 | DBMET00985 | |
| 0.075 | 0.026 | 0.082 | Cathepsin E inhibitor | 0.082 0.021 DBMET00985 | DBMET00985 | |
| 0.137 | 0.088 | 0.307 | Insulin secretagoues | 0.307 0.012 DBMET00984 0.156 0.069 DBMET00985 0.172 0.054 DBMET00986 | DBMET00984 | |
| 0.075 | 0.027 | 0.091 | Nitric oxide donor | 0.091 0.014 DBMET00984 0.057 0.054 DBMET00985 | DBMET00984 | |
| 0.06 | 0.012 | 0.116 | Bradykinin antagonist | 0.116 0.005 DBMET00985 | DBMET00985 | |
| 0.076 | 0.029 | 0.085 | Trypsin inhibitor | 0.085 0.024 DBMET00985 | DBMET00985 | |
| 0.074 | 0.026 | 0.074 | Human rhinovirus A protease inhibitor | 0.069 0.029 DBMET00985 | ||
| 0.056 | 0.009 | 0.061 | Baculoviral IAP repeat-containing protein inhibitor | 0.044 0.041 DBMET00984 0.061 0.005 DBMET00985 0.051 0.019 DBMET00986 | DBMET00985 | |
| 0.127 | 0.08 | 0.137 | Bone formation stimulant | 0.137 0.07 DBMET00985 | DBMET00985 | |
| 0.058 | 0.011 | 0.089 | Arginase inhibitor | 0.056 0.012 DBMET00984 0.089 0.005 DBMET00985 0.038 0.024 DBMET00986 | DBMET00985 | |
| 0.111 | 0.064 | 0.111 | Mucolytic | 0.101 0.076 DBMET00985 | ||
| 0.051 | 0.006 | 0.06 | Bradykinin B2 receptor antagonist | 0.06 0.004 DBMET00985 | DBMET00985 | |
| 0.058 | 0.015 | 0.076 | Glutamate (mGluR4) antagonist | 0.076 0.009 DBMET00985 | DBMET00985 | |
| 0.046 | 0.004 | 0.053 | HCV NS5A inhibitor | 0.033 0.011 DBMET00984 0.053 0.004 DBMET00985 0.038 0.006 DBMET00986 | DBMET00985 | |
| 0.118 | 0.079 | 0.188 | Alpha-N-acetylglucosaminidase inhibitor | 0.141 0.061 DBMET00984 0.188 0.038 DBMET00985 0.115 0.083 DBMET00986 | DBMET00985 | |
| 0.057 | 0.021 | 0.08 | Cholecystokinin antagonist | 0.08 0.011 DBMET00985 | DBMET00985 | |
| 0.044 | 0.01 | 0.056 | Bradykinin B2 receptor agonist | 0.03 0.018 DBMET00984 0.056 0.006 DBMET00985 0.033 0.016 DBMET00986 | DBMET00985 | |
| 0.069 | 0.034 | 0.093 | Neuraminidase inhibitor | 0.071 0.032 DBMET00984 0.07 0.034 DBMET00985 0.093 0.018 DBMET00986 | DBMET00986 | |
| 0.053 | 0.019 | 0.059 | Leukotriene A4 hydrolase inhibitor | 0.059 0.016 DBMET00985 | DBMET00985 | |
| 0.05 | 0.017 | 0.064 | Calcitonin receptor agonist | 0.064 0.014 DBMET00985 | DBMET00985 | |
| 0.055 | 0.025 | 0.098 | Neurotensin receptor antagonist | 0.098 0.014 DBMET00985 | DBMET00985 | |
| 0.147 | 0.117 | 0.15 | Succinate dehydrogenase inhibitor | 0.15 0.112 DBMET00985 | DBMET00985 | |
| 0.05 | 0.021 | 0.064 | Glutamate (mGluR group III) antagonist | 0.064 0.011 DBMET00985 | DBMET00985 | |
| 0.069 | 0.042 | 0.097 | Glucagon-like peptide 1 agonist | 0.097 0.024 DBMET00985 | DBMET00985 | |
| 0.08 | 0.053 | 0.08 | Chymotrypsin inhibitor | 0.075 0.062 DBMET00985 | ||
| 0.057 | 0.032 | 0.124 | NMDA 2A receptor antagonist | 0.124 0.009 DBMET00985 | DBMET00985 | |
| 0.127 | 0.102 | 0.234 | Hemostatic | 0.234 0.024 DBMET00984 0.144 0.076 DBMET00985 | DBMET00984 | |
| 0.049 | 0.024 | 0.061 | Toll-Like receptor 2 agonist | 0.061 0.02 DBMET00984 0.037 0.032 DBMET00985 | DBMET00984 | |
| 0.077 | 0.054 | 0.091 | Somatostatin 1 agonist | 0.091 0.041 DBMET00985 | DBMET00985 | |
| 0.096 | 0.073 | 0.189 | Expectorant | 0.189 0.023 DBMET00984 0.089 0.083 DBMET00985 0.133 0.043 DBMET00986 | DBMET00984 | |
| 0.097 | 0.075 | 0.1 | Factor V inhibitor | 0.1 0.07 DBMET00985 | DBMET00985 | |
| 0.037 | 0.016 | 0.059 | Cholecystokinin B antagonist | 0.059 0.009 DBMET00985 | DBMET00985 | |
| 0.063 | 0.042 | 0.653 | Caspase 9 inhibitor | 0.067 0.036 DBMET00985 0.653 0.001 DBMET00986 | DBMET00986 | |
| 0.03 | 0.009 | 0.03 | Elastase 2 inhibitor | 0.026 0.011 DBMET00985 | ||
| 0.03 | 0.009 | 0.03 | Elastase 2A inhibitor | 0.026 0.011 DBMET00985 | ||
| 0.073 | 0.053 | 0.083 | Glutamate dehydrogenase inhibitor | 0.083 0.042 DBMET00985 | DBMET00985 | |
| 0.046 | 0.027 | 0.058 | Opioid kappa receptor agonist | 0.058 0.019 DBMET00985 | DBMET00985 | |
| 0.116 | 0.098 | 0.116 | Vanilloid 1 agonist | 0.116 0.097 DBMET00984 | ||
| 0.138 | 0.12 | 0.362 | Platelet adhesion inhibitor | 0.362 0.017 DBMET00984 0.146 0.11 DBMET00985 | DBMET00984 | |
| 0.053 | 0.036 | 0.068 | Opioid agonist | 0.068 0.024 DBMET00985 | DBMET00985 | |
| 0.031 | 0.013 | 0.044 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.044 0.006 DBMET00985 | DBMET00985 | |
| 0.063 | 0.047 | 0.063 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.039 | 0.024 | 0.049 | Nicotinic receptor beta4 subunit antagonist | 0.049 0.016 DBMET00985 | DBMET00985 | |
| 0.142 | 0.127 | 0.142 | Catenin beta inhibitor | |||
| 0.08 | 0.066 | 0.097 | Factor XII inhibitor | 0.097 0.04 DBMET00985 | DBMET00985 | |
| 0.062 | 0.049 | 0.094 | Neuraminidase (influenza) inhibitor | 0.075 0.029 DBMET00984 0.059 0.056 DBMET00985 0.094 0.018 DBMET00986 | DBMET00986 | |
| 0.045 | 0.034 | 0.057 | Opioid mu receptor agonist | 0.057 0.025 DBMET00985 | DBMET00985 | |
| 0.022 | 0.011 | 0.023 | Neuraminidase (Influenza B) inhibitor | 0.023 0.01 DBMET00985 | DBMET00985 | |
| 0.074 | 0.063 | 0.078 | Acetylcholine nicotinic antagonist | 0.078 0.056 DBMET00985 | DBMET00985 | |
| 0.067 | 0.057 | 0.075 | Cathepsin G inhibitor | 0.075 0.048 DBMET00985 | DBMET00985 | |
| 0.031 | 0.022 | 0.045 | Caspase 2 inhibitor | 0.045 0.013 DBMET00985 | DBMET00985 | |
| 0.034 | 0.025 | 0.041 | HCV polyprotein inhibitor | 0.041 0.011 DBMET00985 0.033 0.025 DBMET00986 | DBMET00985 | |
| 0.023 | 0.015 | 0.051 | Angiotensin AT2 receptor antagonist | 0.051 0.01 DBMET00985 | DBMET00985 | |
| 0.018 | 0.009 | 0.024 | Dipeptidyl peptidase IX inhibitor | 0.024 0.007 DBMET00985 | DBMET00985 | |
| 0.05 | 0.042 | 0.05 | Acetylcholine M2 receptor agonist | |||
| 0.021 | 0.013 | 0.022 | Baculoviral IAP repeat-containing protein 3 inhibitor | 0.022 0.01 DBMET00985 | DBMET00985 | |
| 0.055 | 0.048 | 0.066 | Lipocortins synthesis agonist | 0.066 0.026 DBMET00984 0.054 0.051 DBMET00986 | DBMET00984 | |
| 0.016 | 0.009 | 0.02 | Dipeptidyl peptidase VIII inhibitor | 0.02 0.007 DBMET00985 | DBMET00985 | |
| 0.043 | 0.036 | 0.066 | Endothelin-converting enzyme inhibitor | 0.066 0.022 DBMET00985 | DBMET00985 | |
| 0.029 | 0.025 | 0.029 | Elastase 3A inhibitor | |||
| 0.029 | 0.025 | 0.029 | Elastase 2B inhibitor | |||
| 0.029 | 0.025 | 0.029 | Elastase 3B inhibitor | |||
| 0.03 | 0.029 | 0.046 | Glutamate (mGluR3) agonist | 0.046 0.006 DBMET00985 | DBMET00985 | |
| 0.013 | 0.013 | 0.031 | Integrin alpha4beta1 antagonist | 0.031 0.007 DBMET00985 | DBMET00985 | |
| 0.031 | 0.03 | 0.036 | Angiotensin II receptor antagonist | 0.036 0.02 DBMET00985 | DBMET00985 | |
| 0.178 | 0.18 | 0.195 | Tyrosine 3 hydroxylase inhibitor | 0.195 0.144 DBMET00985 | DBMET00985 | |
| 0.03 | 0.032 | 0.041 | Carboxypeptidase B inhibitor | 0.041 0.012 DBMET00985 | DBMET00985 | |
| 0.133 | 0.135 | 0.152 | Lipocortins synthesis antagonist | 0.152 0.102 DBMET00985 | DBMET00985 | |
| 0.039 | 0.043 | 0.057 | GP IIb/IIIa receptor antagonist | 0.057 0.029 DBMET00985 | DBMET00985 | |
| 0.04 | 0.044 | 0.055 | Neuraminidase (Influenza A) inhibitor | 0.05 0.023 DBMET00984 0.043 0.037 DBMET00985 0.055 0.017 DBMET00986 | DBMET00986 | |
| 0.03 | 0.035 | 0.037 | Somatostatin 1 antagonist | 0.037 0.028 DBMET00985 | DBMET00985 | |
| 0.037 | 0.044 | 0.04 | Plasmin inhibitor | 0.04 0.039 DBMET00985 | DBMET00985 | |
| 0.022 | 0.03 | 0.058 | AMPA 2 receptor antagonist | 0.058 0.009 DBMET00985 | DBMET00985 | |
| 0.021 | 0.029 | 0.048 | Lysine carboxypeptidase inhibitor | 0.048 0.008 DBMET00985 | DBMET00985 | |
| 0.034 | 0.043 | 0.042 | Integrin alpha1beta1 antagonist | 0.042 0.016 DBMET00985 | DBMET00985 | |
| 0.031 | 0.039 | 0.038 | Cholecystokinin B agonist | 0.038 0.026 DBMET00985 | DBMET00985 | |
| 0.027 | 0.036 | 0.045 | Dipeptidyl peptidase II inhibitor | 0.045 0.011 DBMET00985 | DBMET00985 | |
| 0.104 | 0.113 | 0.14 | Histone deacetylase SIRT1 inhibitor | 0.14 0.071 DBMET00985 | DBMET00985 | |
| 0.02 | 0.031 | 0.032 | Glutamate (mGluR1) agonist | 0.032 0.008 DBMET00985 | DBMET00985 | |
| 0.02 | 0.032 | 0.029 | Bradykinin B1 receptor antagonist | 0.029 0.018 DBMET00985 | DBMET00985 | |
| 0.073 | 0.087 | 0.144 | Transcription factor NF kappa B stimulant | 0.144 0.017 DBMET00984 0.08 0.07 DBMET00986 | DBMET00984 | |
| 0.011 | 0.025 | 0.026 | Aminopeptidase A inhibitor | 0.026 0.008 DBMET00985 | DBMET00985 | |
| 0.012 | 0.027 | 0.018 | Kainate receptor 3 antagonist | 0.018 0.01 DBMET00985 | DBMET00985 | |
| 0.028 | 0.044 | 0.063 | Complement C3a chemotactic receptor antagonist | 0.063 0.02 DBMET00985 | DBMET00985 | |
| 0.034 | 0.049 | 0.04 | Angiotensin AT1 receptor antagonist | 0.04 0.034 DBMET00985 | DBMET00985 | |
| 0.015 | 0.031 | 0.018 | Caspase 8 inhibitor | 0.018 0.016 DBMET00985 | DBMET00985 | |
| 0.014 | 0.032 | 0.017 | Tryptophan hydroxylase 1 inhibitor | 0.017 0.012 DBMET00985 | DBMET00985 | |
| 0.014 | 0.033 | 0.054 | Integrin alpha4 antagonist | 0.054 0.011 DBMET00985 | DBMET00985 | |
| 0.019 | 0.039 | 0.025 | NMDA 2D receptor antagonist | 0.025 0.023 DBMET00985 | DBMET00985 | |
| 0.084 | 0.105 | 0.153 | Toll-Like receptor 4 antagonist | 0.153 0.019 DBMET00984 | DBMET00984 | |
| 0.046 | 0.068 | 0.075 | NMDA 2C receptor antagonist | 0.075 0.029 DBMET00985 | DBMET00985 | |
| 0.053 | 0.076 | 0.079 | Catalase inhibitor | 0.079 0.048 DBMET00985 | DBMET00985 | |
| 0.055 | 0.079 | 0.106 | Aminopeptidase I inhibitor | 0.106 0.025 DBMET00985 | DBMET00985 | |
| 0.039 | 0.063 | 0.049 | Aminopeptidase microsomal inhibitor | 0.049 0.048 DBMET00985 | DBMET00985 | |
| 0.02 | 0.045 | 0.028 | HCV NS5B polymerase inhibitor | 0.028 0.027 DBMET00985 | DBMET00985 | |
| 0.039 | 0.065 | 0.119 | Argininosuccinate synthase inhibitor | 0.119 0.015 DBMET00985 | DBMET00985 | |
| 0.033 | 0.059 | 0.045 | Metalloproteinase-3 inhibitor | 0.045 0.039 DBMET00985 | DBMET00985 | |
| 0.038 | 0.065 | 0.048 | Collagenase inhibitor | 0.048 0.036 DBMET00985 | DBMET00985 | |
| 0.028 | 0.056 | 0.048 | Membrane dipeptidase inhibitor | 0.048 0.017 DBMET00985 | DBMET00985 | |
| 0.063 | 0.093 | 0.103 | NMDA receptor antagonist | 0.103 0.045 DBMET00985 | DBMET00985 | |
| 0.113 | 0.143 | 0.123 | Adenylate cyclase stimulant | 0.123 0.118 DBMET00985 | DBMET00985 | |
| 0.046 | 0.077 | 0.055 | Adenine nucleotide translocase inhibitor | 0.055 0.04 DBMET00984 | DBMET00984 | |
| 0.02 | 0.053 | 0.083 | Integrin antagonist | 0.083 0.019 DBMET00985 | DBMET00985 | |
| 0.01 | 0.044 | 0.021 | Kainate receptor 5 antagonist | 0.021 0.014 DBMET00985 | DBMET00985 | |
| 0.03 | 0.065 | 0.049 | Nicotinic receptor alpha3 subunit antagonist | 0.049 0.025 DBMET00985 | DBMET00985 | |
| 0.012 | 0.048 | 0.024 | Kainate receptor 4 antagonist | 0.024 0.018 DBMET00985 | DBMET00985 | |
| 0.187 | 0.223 | 0.239 | Antiobesity | 0.228 0.178 DBMET00984 0.239 0.167 DBMET00985 | DBMET00985 | |
| 0.021 | 0.058 | 0.05 | NMDA receptor subunit 3A antagonist | 0.05 0.02 DBMET00985 | DBMET00985 | |
| 0.018 | 0.055 | 0.031 | Peptide deformylase inhibitor | 0.031 0.02 DBMET00985 | DBMET00985 | |
| 0.124 | 0.161 | 0.137 | Heat shock protein 70 antagonist | 0.137 0.087 DBMET00985 | DBMET00985 | |
| 0.03 | 0.069 | 0.068 | Ornithine carbamoyltransferase inhibitor | 0.068 0.026 DBMET00985 | DBMET00985 | |
| 0.006 | 0.045 | 0.044 | Kainate receptor 1 antagonist | 0.044 0.006 DBMET00985 | DBMET00985 | |
| 0.026 | 0.066 | 0.04 | Integrin alpha5beta1 antagonist | 0.04 0.029 DBMET00985 | DBMET00985 | |
| 0.068 | 0.109 | 0.162 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.162 0.023 DBMET00985 | DBMET00985 | |
| 0.092 | 0.134 | 0.11 | Interleukin 4 antagonist | 0.11 0.101 DBMET00984 | DBMET00984 | |
| 0.02 | 0.063 | 0.061 | Kainate receptor antagonist | 0.061 0.015 DBMET00985 | DBMET00985 | |
| 0.088 | 0.133 | 0.248 | Lipid peroxidase inhibitor | 0.248 0.027 DBMET00984 0.11 0.104 DBMET00986 | DBMET00984 | |
| 0.212 | 0.258 | 0.493 | Apoptosis agonist | 0.493 0.076 DBMET00984 0.328 0.153 DBMET00986 | DBMET00984 | |
| 0.038 | 0.086 | 0.048 | CD45 antagonist | 0.048 0.04 DBMET00985 | DBMET00985 | |
| 0.026 | 0.074 | 0.047 | Ribonucleoside-diphosphate reductase inhibitor | 0.047 0.043 DBMET00985 | DBMET00985 | |
| 0.039 | 0.088 | 0.061 | Matrix metalloproteinase inhibitor | 0.061 0.053 DBMET00985 | DBMET00985 | |
| 0.064 | 0.114 | 0.14 | Prolactin inhibitor | 0.14 0.026 DBMET00985 | DBMET00985 | |
| 0.025 | 0.076 | 0.047 | Ribonucleotide reductase inhibitor | 0.047 0.044 DBMET00985 | DBMET00985 | |
| 0.016 | 0.067 | 0.028 | LFA antagonist | 0.028 0.019 DBMET00985 | DBMET00985 | |
| 0.121 | 0.173 | 0.235 | Hypolipemic | 0.235 0.075 DBMET00984 | DBMET00984 | |
| 0.075 | 0.13 | 0.098 | Nav1.4 sodium channel blocker | 0.098 0.078 DBMET00985 | DBMET00985 | |
| 0.142 | 0.201 | 0.223 | Superoxide dismutase inhibitor | 0.223 0.095 DBMET00985 | DBMET00985 | |
| 0.029 | 0.092 | 0.053 | Kainate receptor agonist | 0.053 0.011 DBMET00985 | DBMET00985 | |
| 0.103 | 0.171 | 0.301 | Nitric oxide antagonist | 0.301 0.04 DBMET00984 0.17 0.082 DBMET00986 | DBMET00984 | |
| 0.073 | 0.146 | 0.11 | Microtubule formation inhibitor | 0.11 0.074 DBMET00984 | DBMET00984 | |
| 0.047 | 0.124 | 0.073 | Metalloproteinase-2 inhibitor | 0.073 0.061 DBMET00985 | DBMET00985 | |
| 0.029 | 0.109 | 0.291 | Selectin antagonist | 0.252 0.008 DBMET00984 0.291 0.006 DBMET00986 | DBMET00986 | |
| 0.005 | 0.088 | 0.024 | VLA-4 antagonist | 0.024 0.02 DBMET00985 | DBMET00985 | |
| 0.021 | 0.115 | 0.06 | NMDA receptor subunit 3B antagonist | 0.06 0.019 DBMET00985 | DBMET00985 | |
| 0.053 | 0.151 | 0.089 | Falcipain 3 inhibitor | 0.089 0.083 DBMET00985 | DBMET00985 | |
| 0.035 | 0.137 | 0.064 | NMDA receptor agonist | 0.064 0.042 DBMET00985 | DBMET00985 | |
| 0.211 | 0.318 | 0.85 | Antiinflammatory | 0.657 0.039 DBMET00984 0.85 0.009 DBMET00986 | DBMET00986 | |
| 0.058 | 0.17 | 0.114 | DNA polymerase I inhibitor | 0.114 0.073 DBMET00984 | DBMET00984 | |
| 0.021 | 0.141 | 0.084 | Protein 50S ribosomal subunit inhibitor | 0.069 0.025 DBMET00984 0.084 0.018 DBMET00986 | DBMET00986 | |
| 0.019 | 0.148 | 0.052 | AMPA 4 receptor antagonist | 0.052 0.014 DBMET00985 | DBMET00985 | |
| 0.129 | 0.263 | 0.302 | Peptidyltransferase inhibitor | 0.302 0.024 DBMET00984 0.27 0.038 DBMET00986 | DBMET00984 | |
| 0.015 | 0.152 | 0.037 | Glutamate (mGluR3) antagonist | 0.037 0.025 DBMET00985 | DBMET00985 | |
| 0.019 | 0.157 | 0.069 | NMDA 2 receptor antagonist | 0.069 0.052 DBMET00985 | DBMET00985 | |
| 0.016 | 0.157 | 0.027 | Toll-Like receptor 4 agonist | 0.027 0.016 DBMET00984 0.025 0.022 DBMET00986 | DBMET00984 | |
| 0.095 | 0.237 | 0.359 | Free radical scavenger | 0.359 0.037 DBMET00984 0.164 0.13 DBMET00986 | DBMET00984 | |
| 0.022 | 0.169 | 0.055 | Alpha-mannosidase inhibitor | 0.055 0.035 DBMET00984 | DBMET00984 | |
| 0.025 | 0.186 | 0.05 | Glucose-6-phosphate translocase inhibitor | 0.05 0.038 DBMET00984 | DBMET00984 | |
| 0.019 | 0.184 | 0.115 | Antineoplastic antibiotic | 0.1 0.046 DBMET00984 0.115 0.04 DBMET00986 | DBMET00986 | |
| 0.019 | 0.188 | 0.09 | Phosphofructokinase-1 inhibitor | 0.09 0.036 DBMET00986 | DBMET00986 | |
| 0.182 | 0.35 | 0.283 | Caspase 9 stimulant | 0.283 0.213 DBMET00984 | DBMET00984 | |
| 0.018 | 0.188 | 0.051 | Antibiotic Aminoglycoside-like | 0.051 0.013 DBMET00984 | DBMET00984 | |
| 0.138 | 0.318 | 0.495 | Antibacterial | 0.495 0.042 DBMET00984 0.442 0.06 DBMET00986 | DBMET00984 | |
| 0.088 | 0.281 | 0.403 | Antioxidant | 0.403 0.034 DBMET00984 0.244 0.087 DBMET00986 | DBMET00984 | |
| 0.078 | 0.272 | 0.251 | Antiamyloidogenic | 0.251 0.071 DBMET00984 | DBMET00984 | |
| 0.132 | 0.331 | 0.237 | Caspase 3 stimulant | 0.237 0.124 DBMET00984 | DBMET00984 | |
| 0.077 | 0.287 | 0.212 | Non-steroidal antiinflammatory agent | 0.212 0.062 DBMET00984 | DBMET00984 | |
| 0.016 | 0.25 | 0.079 | Glutamate receptor agonist | 0.079 0.054 DBMET00985 | DBMET00985 | |
| 0.048 | 0.302 | 0.121 | Cyclooxygenase 3 inhibitor | 0.121 0.076 DBMET00984 | DBMET00984 | |
| 0.007 | 0.292 | 0.022 | Protein 30S ribosomal subunit inhibitor | 0.022 0.02 DBMET00984 | DBMET00984 | |
| 0.057 | 0.382 | 0.289 | Tumour necrosis factor alpha release inhibitor | 0.289 0.058 DBMET00984 | DBMET00984 | |
| 0.017 | 0.499 | 0.123 | ATPase (Vacuolar H+) inhibitor | 0.123 0.018 DBMET00986 | DBMET00986 | |
| 0.008 | 0.669 | 0.103 | Topoisomerase I inhibitor | 0.103 0.068 DBMET00984 | DBMET00984 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |